KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
603233 DaShenLin Pharmaceutical Group
- 16.22
- -0.27-1.64%
Market Closed Dec 13 15:00 CST
18.47BMarket Cap21.71P/E (TTM)
16.60High16.14Low154.19KlotVolume16.35Open16.49Pre Close251.54MTurnover1.35%Turnover Ratio15.84P/E (Static)1.14BShares26.4852wk High2.77P/B18.47BFloat Cap11.6152wk Low18.14Limit Up1.14BShs Float59.70Historical High14.84Limit Down2.79%Amplitude8.34Historical Low0.62Dividend TTM16.31Avg Price78.57KlotAsk3.82%Div YieldTTM100Lot Size68.69KlotBid
DaShenLin Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 11.33%19.73B | 11.29%13.35B | 13.54%6.75B | 15.45%24.53B | 19.61%17.72B | 23.37%11.99B | 27.16%5.95B | 26.78%21.25B | 19.93%14.82B | 20.68%9.72B |
| Operating revenue | 11.33%19.73B | 11.29%13.35B | 13.54%6.75B | 15.45%24.53B | 19.61%17.72B | 23.37%11.99B | 27.16%5.95B | 26.78%21.25B | 19.93%14.82B | 20.68%9.72B |
| Other operating revenue | ---- | 5.47%307.1M | ---- | 28.29%599.94M | ---- | 2.65%291.18M | ---- | -0.02%467.67M | ---- | 17.76%283.66M |
| Total operating cost | 15.29%18.61B | 15.77%12.47B | 17.97%6.2B | 15.36%22.9B | 18.49%16.14B | 22.12%10.77B | 25.80%5.25B | 25.34%19.85B | 19.64%13.62B | 20.85%8.82B |
| Operating cost | 15.54%12.89B | 15.82%8.69B | 18.47%4.36B | 18.97%15.72B | 22.96%11.16B | 27.64%7.5B | 34.54%3.68B | 27.51%13.22B | 18.91%9.07B | 19.82%5.88B |
| Operating tax surcharges | 29.48%78.24M | 25.86%51.18M | 23.39%23.39M | 18.42%94.68M | 12.57%60.43M | 14.42%40.66M | 9.72%18.96M | 17.36%79.95M | 14.60%53.68M | 18.20%35.54M |
| Operating expense | 18.01%4.61B | 17.16%3.03B | 17.79%1.47B | 8.98%5.62B | 9.15%3.9B | 11.28%2.58B | 9.66%1.25B | 20.95%5.16B | 19.86%3.58B | 21.63%2.32B |
| Administration expense | 0.24%836.95M | 8.89%573.77M | 13.08%281.72M | 6.74%1.18B | 12.83%834.92M | 12.49%526.93M | 13.20%249.14M | 20.55%1.11B | 22.35%739.96M | 23.96%468.41M |
| Financial expense | -0.19%150.88M | 6.24%103.36M | 16.70%51.21M | -8.41%190.15M | 4.45%151.16M | -3.96%97.29M | -24.07%43.88M | 21.97%207.61M | 29.09%144.73M | 40.49%101.29M |
| -Interest expense (Financial expense) | -3.36%175.63M | 3.03%123.85M | 3.31%62.25M | 3.14%239.26M | 1.33%181.73M | -0.52%120.2M | 4.12%60.25M | 9.40%231.97M | 18.26%179.35M | 30.84%120.83M |
| -Interest Income (Financial expense) | 12.11%-53.11M | 8.81%-38.42M | 2.72%-18.99M | -35.06%-85.19M | -39.31%-60.43M | -72.68%-42.14M | -100.26%-19.52M | 7.61%-63.08M | 29.01%-43.38M | 43.85%-24.4M |
| Research and development | 33.16%47.99M | 22.25%29.87M | -12.48%12.8M | 8.81%80.93M | 0.94%36.04M | 32.20%24.43M | 69.01%14.62M | 66.74%74.38M | 277.15%35.7M | 178.12%18.48M |
| Credit Impairment Loss | 78.47%-1.81M | 68.86%-2.05M | 43.13%-1.29M | 11.13%-29.69M | -85.66%-8.4M | 38.01%-6.6M | -38.84%-2.28M | -135.18%-33.4M | 38.98%-4.53M | -50.84%-10.64M |
| Asset Impairment Loss | 62.02%-7.7M | 34.48%-11.28M | 90.54%-2.19M | -765.79%-77.21M | -204.20%-20.27M | -210.62%-17.21M | -7,521.88%-23.11M | 54.42%-8.92M | 15.82%-6.66M | 0.54%-5.54M |
| Other net revenue | 173.37%66.5M | 127.33%32.24M | 226.99%14.18M | -109.76%-2.06M | -17.58%24.33M | -56.25%14.18M | -13.40%-11.17M | -81.85%21.16M | -74.14%29.51M | -68.51%32.42M |
| Fair value change income | -159.53%-4.95M | -226.28%-3.95M | -91.08%-3.55M | 123.43%4.38M | 126.72%8.31M | 121.53%3.13M | 92.97%-1.86M | -154.11%-18.71M | -150.87%-31.1M | -119.56%-14.54M |
| Invest income | -99.06%36.21K | -99.39%19.78K | ---- | 12.84%6.56M | 27.34%3.84M | 238.40%3.26M | -134.52%-122.01K | -38.33%5.81M | -78.62%3.02M | -134.33%-2.36M |
| -Including: Investment income associates | ---- | ---- | ---- | -210.87%-142.5K | -219.28%-111.79K | -355.29%-111.79K | ---- | 65.21%-45.84K | 70.72%-35.01K | 68.17%-24.55K |
| Asset deal income | 161.99%1.78M | -636.41%-6.54M | -468.63%-1.8M | -81.69%3.43M | -292.57%-2.87M | -9.78%1.22M | -60.70%488.11K | 232.49%18.73M | 327.54%1.49M | 15.21%1.35M |
| Other revenue | 81.01%79.14M | 84.46%56.05M | 46.48%23.01M | 56.93%90.46M | -35.03%43.72M | -52.63%30.39M | -7.17%15.71M | -42.78%57.64M | 24.88%67.29M | 92.96%64.14M |
| Operating profit | -26.04%1.19B | -26.57%905.27M | -16.55%570.86M | 14.85%1.63B | 31.16%1.6B | 32.37%1.23B | 38.93%684.09M | 36.54%1.42B | 13.06%1.22B | 8.60%931.34M |
| Add:Non operating Income | 126.88%22.95M | 52.87%9.68M | -58.18%2.51M | 9.03%26.28M | -37.18%10.12M | -54.76%6.33M | 113.91%6.01M | 112.20%24.1M | 126.19%16.11M | 210.68%14M |
| Less:Non operating expense | 25.08%30.28M | 13.03%14.11M | -87.22%1.37M | 1.12%30.34M | 80.17%24.21M | 54.88%12.48M | 694.18%10.74M | 275.98%30M | 24.75%13.43M | -4.42%8.06M |
| Total profit | -25.85%1.18B | -26.56%900.85M | -15.80%572M | 15.05%1.63B | 29.73%1.59B | 30.87%1.23B | 37.56%679.36M | 35.54%1.41B | 13.69%1.23B | 9.80%937.28M |
| Less:Income tax cost | -27.87%265.22M | -26.74%199.75M | -23.72%118.31M | 18.32%397.12M | 22.25%367.72M | 21.48%272.66M | 40.56%155.09M | 40.12%335.62M | 20.57%300.8M | 13.83%224.45M |
| Add:Adjusted items effecting net profit | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- | ---- | ---- |
| Net profit | -25.24%914.06M | -26.51%701.1M | -13.46%453.69M | 14.03%1.23B | 32.16%1.22B | 33.83%953.98M | 36.70%524.26M | 34.17%1.08B | 11.62%925.11M | 8.59%712.83M |
| Net profit from continuing operation | -25.24%914.06M | -26.51%701.1M | -13.46%453.69M | 14.03%1.23B | 32.16%1.22B | 33.83%953.98M | 36.70%524.26M | 34.17%1.08B | 11.62%925.11M | 8.59%712.83M |
| Less:Minority Profit | 15.94%55.94M | 19.01%43.5M | 100.79%55.24M | 47.33%64.16M | 2,478.55%48.25M | 2,793.63%36.55M | 3,964.83%27.51M | 230.83%43.55M | -82.18%1.87M | -112.54%-1.36M |
| Net profit of parent company owners | -26.93%858.12M | -28.32%657.59M | -19.79%398.45M | 12.63%1.17B | 27.20%1.17B | 28.46%917.43M | 29.29%496.75M | 30.90%1.04B | 12.82%923.24M | 10.62%714.19M |
| Earning per share | ||||||||||
| Basic earning per share | -27.18%0.75 | -28.40%0.58 | -32.69%0.35 | 13.19%1.03 | 27.16%1.03 | 8.00%0.81 | 6.12%0.52 | 8.33%0.91 | -5.81%0.81 | 10.29%0.75 |
| Diluted earning per share | -27.18%0.75 | -28.40%0.58 | -32.69%0.35 | 13.19%1.03 | 27.16%1.03 | 8.00%0.81 | 6.12%0.52 | 8.33%0.91 | -5.81%0.81 | 10.29%0.75 |
| Other composite income | ||||||||||
| Total composite income | -25.24%914.06M | -26.51%701.1M | -13.46%453.69M | 14.03%1.23B | 32.16%1.22B | 33.83%953.98M | 36.70%524.26M | 34.17%1.08B | 11.62%925.11M | 8.59%712.83M |
| Total composite income of parent company owners | -26.93%858.12M | -28.32%657.59M | -19.79%398.45M | 12.63%1.17B | 27.20%1.17B | 28.46%917.43M | 29.29%496.75M | 30.90%1.04B | 12.82%923.24M | 10.62%714.19M |
| Total composite income of minority owners | 15.94%55.94M | 19.01%43.5M | 100.79%55.24M | 47.33%64.16M | 2,478.55%48.25M | 2,793.63%36.55M | 3,964.83%27.51M | 230.83%43.55M | -82.18%1.87M | -112.54%-1.36M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
